Patents by Inventor Joseph Chappell
Joseph Chappell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220127309Abstract: Disclosed are chimeric polypeptides based on viral membrane fusion proteins. More particularly, the present invention discloses chimeric polypeptides that comprise a virion surface exposed portion of a viral fusion protein and a heterologous structure-stabilizing moiety, and to complexes of those chimeric polypeptides. The present invention also discloses the use of these complexes in compositions and methods for eliciting an immune response to a fusion protein of an enveloped virus, or complex of the fusion protein, and/or for treating or preventing an enveloped virus infection. The present invention further discloses the use of the heterologous structure-stabilizing moiety for oligomerizing heterologous molecules of interest.Type: ApplicationFiled: January 11, 2022Publication date: April 28, 2022Applicant: The University of QueenslandInventors: Keith Joseph CHAPPELL, Daniel WATTERSON, Paul Robert YOUNG
-
Patent number: 11254712Abstract: Disclosed are chimeric polypeptides based on viral membrane fusion proteins. More particularly, the present invention discloses chimeric polypeptides that comprise a virion surface exposed portion of a viral fusion protein and a heterologous structure-stabilizing moiety, and to complexes of those chimeric polypeptides. The present invention also discloses the use of these complexes in compositions and methods for eliciting an immune response to a fusion protein of an enveloped virus, or complex of the fusion protein, and/or for treating or preventing an enveloped virus infection. The present invention further discloses the use of the heterologous structure-stabilizing moiety for oligomerizing heterologous molecules of interest.Type: GrantFiled: March 29, 2018Date of Patent: February 22, 2022Assignee: The University of QueenslandInventors: Keith Joseph Chappell, Daniel Watterson, Paul Robert Young
-
Publication number: 20200040042Abstract: Disclosed are chimeric polypeptides based on viral membrane fusion proteins. More particularly, the present invention discloses chimeric polypeptides that comprise a virion surface exposed portion of a viral fusion protein and a heterologous structure-stabilizing moiety, and to complexes of those chimeric polypeptides. The present invention also discloses the use of these complexes in compositions and methods for eliciting an immune response to a fusion protein of an enveloped virus, or complex of the fusion protein, and/or for treating or preventing an enveloped virus infection. The present invention further discloses the use of the heterologous structure-stabilizing moiety for oligomerizing heterologous molecules of interest.Type: ApplicationFiled: March 29, 2018Publication date: February 6, 2020Inventors: Keith Joseph CHAPPELL, Daniel WATTERSON, Paul Robert YOUNG
-
Patent number: 10184118Abstract: The invention relates to isolated cytochrome P450 polypeptides and nucleic acid molecules, as well as expression vectors and transgenic plants containing these molecules. In addition, the invention relates to uses of such molecules in methods of increasing the level of resistance against a disease caused by a plant pathogen in a transgenic plant, in methods for producing altered compounds, for example, hydroxylated compounds, and in methods of producing isoprenoid compounds.Type: GrantFiled: August 24, 2015Date of Patent: January 22, 2019Assignee: The University of Kentucky Research FoundationInventors: Joseph Chappell, Lyle F. Ralston
-
Patent number: 10184119Abstract: The invention relates to isolated cytochrome P450 polypeptides and nucleic acid molecules, as well as expression vectors and transgenic plants containing these molecules. In addition, the invention relates to uses of such molecules in methods of increasing the level of resistance against a disease caused by a plant pathogen in a transgenic plant, in methods for producing altered compounds, for example, hydroxylated compounds, and in methods of producing isoprenoid compounds.Type: GrantFiled: August 24, 2015Date of Patent: January 22, 2019Assignee: The University of Kentucky Research FoundationInventors: Joseph Chappell, Lyle F. Ralston
-
Patent number: 10106826Abstract: The present invention provides methods of producing biological products or increasing production of such products through expression in a plant of a bacterial or plant glycolate catabolic cycle gene, such as glycolate dehydrogenease (GDH), glycolate oxidase (GO), or malate synthase (MS) in combination with a plant gene, such as farnesyl diphosphate synthase (FPS), squalene synthase (SQS), or PLAS. Also provided are plants, plants parts and compositions produced through methods of the present invention. The invention leads to two to five fold increase of end product yield.Type: GrantFiled: February 28, 2014Date of Patent: October 23, 2018Assignees: The Texas A&M University System, The University of Illinois at Urbana Champaign, University of KentuckyInventors: Shuhua (Joshua) Yuan, Donald Ort, Joseph Chappell, Xinguang Zhu, Hong Ma, Yong Kyoung Kim
-
Patent number: 9842089Abstract: A method for managing display of electronic documents is described. A user interface is generated for a visual style set of visual styles that affect display of electronic document content. A visual style of the visual style set comprises a style element set of style elements. A lock status for a style element of the style element set is received via the user interface. The lock status indicates whether the style element is editable or non-editable by a user of an electronic document associated with the visual style set. The visual style set is stored with the lock status for the style element.Type: GrantFiled: January 14, 2016Date of Patent: December 12, 2017Assignee: Workiva Inc.Inventors: Joel Alan Marks, Winston Joseph Chappell, Edward Yee Ly, Edward Joseph Cupps, Alan Joseph Streit, John Patrick Ryan
-
Patent number: 9534237Abstract: The invention relates to sesquiterpene synthases and methods for their production and use. Particularly, the invention provides nucleic acids comprising the nucleotide sequence of citrus valencene synthase (CVS) which codes for at least one CVS. The invention further provides nucleic acids comprising the nucleotide sequence coding for amino acid residues forming the tier 1 and tier 2 domains of CVS. The invention also provides for methods of making and using the nucleic acids and amino acids of the current invention.Type: GrantFiled: August 13, 2014Date of Patent: January 3, 2017Assignee: University of Kentucky Research FoundationInventors: Joseph Chappell, Bryan Greenhagen
-
Publication number: 20160132465Abstract: A method for managing display of electronic documents is described. A user interface is generated for a visual style set of visual styles that affect display of electronic document content. A visual style of the visual style set comprises a style element set of style elements. A lock status for a style element of the style element set is received via the user interface. The lock status indicates whether the style element is editable or non-editable by a user of an electronic document associated with the visual style set. The visual style set is stored with the lock status for the style element.Type: ApplicationFiled: January 14, 2016Publication date: May 12, 2016Inventors: Joel Alan Marks, Winston Joseph Chappell, Edward Yee Ly, Edward Joseph Cupps, Alan Joseph Streit, John Patrick Ryan
-
Publication number: 20160032256Abstract: The invention features isolated cytochrome P450 polypeptides and nucleic acid molecules, as well as expression vectors and transgenic plants containing these molecules. In addition, the invention features uses of such molecules in methods of increasing the level of resistance against a disease caused by a plant pathogen in a transgenic plant, in methods for producing altered compounds, for example, hydroxylated compounds, and in methods of producing isoprenoid compounds.Type: ApplicationFiled: August 24, 2015Publication date: February 4, 2016Applicant: UNIVERSITY OF KENTUCKY RESEARCH FOUNDATIONInventors: Joseph Chappell, Lyle F. Ralston
-
Publication number: 20160024530Abstract: The invention features isolated cytochrome P450 polypeptides and nucleic acid molecules, as well as expression vectors and transgenic plants containing these molecules. In addition, the invention features uses of such molecules in methods of increasing the level of resistance against a disease caused by a plant pathogen in a transgenic plant, in methods for producing altered compounds, for example, hydroxylated compounds, and in methods of producing isoprenoid compounds.Type: ApplicationFiled: August 24, 2015Publication date: January 28, 2016Applicant: UNIVERSITY OF KENTUCKY RESEARCH FOUNDATIONInventors: Joseph Chappell, Lyle F. Ralston
-
Patent number: 9239820Abstract: A method for managing display of electronic documents is described. A user interface is generated for a visual style set of visual styles that affect display of electronic document content. A visual style of the visual style set comprises a style element set of style elements. A lock status for a style element of the style element set is received via the user interface. The lock status indicates whether the style element is editable or non-editable by a user of an electronic document associated with the visual style set. The visual style set is stored with the lock status for the style element.Type: GrantFiled: August 4, 2014Date of Patent: January 19, 2016Assignee: Workiva Inc.Inventors: Joel Alan Marks, Winston Joseph Chappell, Edward Yee Ly, Edward Joseph Cupps, Alan Joseph Streit, John Patrick Ryan
-
Publication number: 20140356926Abstract: The invention relates to sesquiterpene synthases and methods for their production and use. Particularly, the invention provides nucleic acids comprising the nucleotide sequence of citrus valencene synthase (CVS) which codes for at least one CVS. The invention further provides nucleic acids comprising the nucleotide sequence coding for amino acid residues forming the tier 1 and tier 2 domains of CVS. The invention also provides for methods of making and using the nucleic acids and amino acids of the current invention.Type: ApplicationFiled: August 13, 2014Publication date: December 4, 2014Inventors: Joseph Chappell, Bryan Greenhagen
-
Publication number: 20140283219Abstract: The present invention provides methods of producing biological products or increasing production of such products through expression in a plant of a bacterial or plant glycolate catabolic cycle gene, such as glycolate dehydrogenease (GDH), glycolate oxidase (GO), or malate synthase (MS) in combination with a plant gene, such as farnesyl diphosphate synthase (FPS), squalene synthase (SQS), or PLAS. Also provided are plants, plants parts and compositions produced through methods of the present invention. The invention leads to two to five fold increase of end product yield.Type: ApplicationFiled: February 28, 2014Publication date: September 18, 2014Applicants: The Texas A&M University System, The University of Illinois at Urbana Champaign, University of KentuckyInventors: Shuhua (Joshua) Yuan, Donald Ort, Joseph Chappell, Xinguang Zhu, Hong Ma, Yong Kyoung Kim
-
Patent number: 8835131Abstract: The invention relates to sesquiterpene synthases and methods for their production and use. Particularly, the invention provides nucleic acids comprising the nucleotide sequence of citrus valencene synthase (CVS) which codes for at least one CVS. The invention further provides nucleic acids comprising the nucleotide sequence coding for amino acid residues forming the tier 1 and tier 2 domains of CVS. The invention also provides for methods of making and using the nucleic acids and amino acids of the current invention.Type: GrantFiled: March 6, 2012Date of Patent: September 16, 2014Assignee: University of Kentucky Research FoundationInventors: Joseph Chappell, Bryan Greenhagen
-
Publication number: 20140242660Abstract: Provided is a chimeric isoprenoid synthase polypeptide including a first domain from a first isoprenoid synthase joined to a second domain from a second, heterologous, isoprenoid synthase, whereby the chimeric isoprenoid synthase is capable of catalyzing the production of isoprenoid reaction products that are not produced in the absence of the second domain of the second, heterologous, isoprenoid synthase. Also provided is a chimeric isoprenoid synthase polypeptide including an asymmetrically positioned heterologous domain, whereby the chimeric isoprenoid synthase is capable of catalyzing the production of isoprenoid reaction products that are not produced when the domain is positioned at its naturally-occurring site in the isoprenoid synthase polypeptide.Type: ApplicationFiled: May 2, 2014Publication date: August 28, 2014Inventors: Joseph Chappell, Kyoungwhan Back
-
Publication number: 20140212939Abstract: The invention features isolated cytochrome P450 polypeptides and nucleic acid molecules, as well as expression vectors and transgenic plants containing these molecules. In addition, the invention features uses of such molecules in methods of increasing the level of resistance against a disease caused by a plant pathogen in a transgenic plant, in methods for producing altered compounds, for example, hydroxylated compounds, and in methods of producing isoprenoid compounds.Type: ApplicationFiled: April 2, 2014Publication date: July 31, 2014Inventors: JOSEPH CHAPPELL, LYLE F. RALSTON
-
Patent number: 8741651Abstract: Provided is a chimeric isoprenoid synthase polypeptide including a first domain from a first isoprenoid synthase joined to a second domain from a second, heterologous, isoprenoid synthase, whereby the chimeric isoprenoid synthase is capable of catalyzing the production of isoprenoid reaction products that are not produced in the absence of the second domain of the second, heterologous, isoprenoid synthase. Also provided is a chimeric isoprenoid synthase polypeptide including an asymmetrically positioned heterologous domain, whereby the chimeric isoprenoid synthase is capable of catalyzing the production of isoprenoid reaction products that are not produced when the domain is positioned at its naturally-occurring site in the isoprenoid synthase polypeptide.Type: GrantFiled: October 26, 2012Date of Patent: June 3, 2014Assignee: The Board of Trustees of The University of KentuckyInventors: Joseph Chappell, Kyoungwhan Back
-
Patent number: 8704040Abstract: Provided is an isolated polypeptide having triterpene methyltransferase activity. Also provided is an isolated nucleic acid molecule that encodes the triterpene methyltransferase polypeptides; a vector comprising the nucleic acid molecules that encode the triterpene methyltransferase polypeptides; and a host cell(s) transfected with the aforementioned nucleic acid molecule or vector. In another aspect, a method of producing a methylated triterpene is provided. The method comprises providing a metabolizable carbon source to a host cell transfected with a nucleic acid molecule that encodes a triterpene methyltransferase under conditions sufficient for production of a methylated triterpene. The method optionally further comprises isolating the methylated triterpene produced by the host cell.Type: GrantFiled: June 22, 2009Date of Patent: April 22, 2014Assignee: University of Kentucky Research FoundationInventors: Joseph Chappell, Shigeru Okada, Scott Kinison, Tom Niehaus
-
Publication number: 20130330793Abstract: The invention features isolated cytochrome P450 polypeptides and nucleic acid molecules, as well as expression vectors and transgenic plants containing these molecules. In addition, the invention features uses of such molecules in methods of increasing the level of resistance against a disease caused by a plant pathogen in a transgenic plant, in methods for producing altered compounds, for example, hydroxylated compounds, and in methods of producing isoprenoid compounds.Type: ApplicationFiled: May 3, 2013Publication date: December 12, 2013Inventors: Joseph Chappell, Lyle F. Ralston